T Hickish
Overview
Explore the profile of T Hickish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
2001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Powles R, Raje N, Horton C, Mehta J, Singhal S, Hickish T, et al.
Leuk Lymphoma
. 1996 May;
21(5-6):421-7.
PMID: 9172806
Interferon (INF) has been incorporated as part of maintenance therapy after high dose treatment in order to make remissions more durable. In this study we have compared peripheral blood stem...
32.
OBrien M, Milan S, Cunningham D, Jones A, Nicolson M, Selby P, et al.
Br J Cancer
. 1996 May;
73(10):1272-7.
PMID: 8630292
High-dose chemotherapy with autologous bone marrow transplantation is used in the treatment of relapsed or high-risk Hodgkin's disease. As prospective randomised studies have proved difficult to accrue to, current recommendations...
33.
Findlay M, Young H, Cunningham D, Iveson A, Cronin B, Hickish T, et al.
J Clin Oncol
. 1996 Mar;
14(3):700-8.
PMID: 8622014
Purpose: To investigate and measure the metabolism of colorectal cancer liver metastases using 18F-fluorodeoxyglucose positron emission tomography (FDG PET), before and during the first month of chemotherapy. The findings were...
34.
Powles T, Hickish T, Kanis J, Tidy A, Ashley S
J Clin Oncol
. 1996 Jan;
14(1):78-84.
PMID: 8558225
Purpose: Tamoxifen is an effective treatment for metastatic and primary breast cancer and is now being evaluated as a chemoprevention agent in healthy women. Any long-term effects on estrogen-sensitive tissues...
35.
Modjtahedi H, Hickish T, Nicolson M, Moore J, Styles J, Eccles S, et al.
Br J Cancer
. 1996 Jan;
73(2):228-35.
PMID: 8546911
The purpose of this study was to determine the effect of the first rat monoclonal antibody (MAb ICR62) to the epidermal growth factor receptor (EGFR) in a phase I clinical...
36.
Nicolson M, Webb A, Cunningham D, Norman A, OBrien M, Hill A, et al.
Ann Oncol
. 1995 Oct;
6(8):801-4.
PMID: 8589018
Purpose: The combination of protracted venous infusion (PVI) 5-FU with moderate dose cisplatin was evaluated in patients with advanced pancreatic cancer. Patients And Methods: Sixty-three patients with locally advanced or...
37.
Powles T, Hickish T
J Natl Cancer Inst
. 1995 Sep;
87(18):1343-5.
PMID: 7658489
No abstract available.
38.
Hill M, Norman A, Cunningham D, Findlay M, Watson M, Nicolson V, et al.
J Clin Oncol
. 1995 Sep;
13(9):2317-23.
PMID: 7666089
Purpose: The aim of this study was to investigate the effects of adding interferon alfa-2b (IFN) to protracted venous infusion fluorouracil (PVI 5-FU) from the start of treatment in patients...
39.
Ellis P, Norman A, Hill A, OBrien M, Nicolson M, Hickish T, et al.
Eur J Cancer
. 1995 Sep;
31A(10):1594-8.
PMID: 7488407
Hepatobiliary tumours are rare, often present late and have a poor prognosis, with no current effective systemic therapy available. This study aimed to evaluate the activity and toxicity of epirubicin,...
40.